Psoriasis is a common skin condition that accelerates the life cycle of skin cells. More than 3% of the adult population in the United States suffers from psoriasis. That equates to more than 7.5 m...
HUTCHMED Completes Rolling Submission of NDA to FDA for Fruquintinib HUTCHMED (China) Limited announced the completion of the rolling submission of a New Drug Application ("NDA") to the United States Food and Drug Administration ("FDA") for fruquintinib, its highly selective and potent oral inhibitor of VEGFR-1,...
Find MoreRett syndrome is a rare progressive neurodevelopmental disorder primarily affecting women. Males are only occasionally affected. Infants with Rett syndrome typically develop normally for the first 7 to 18 months of life. The Rett syndrome prevalence in the United States is estimated to be 1 in 10K girls by the age ...
Find MorePeripheral artery disease (PAD) is one of the leading causes of cardiovascular morbidity, affecting 12-14% of the world’s population. Peripheral artery disease affects six times more people worldwide than HIV. 1 in 3 diabetics over age 50 suffer from peripheral artery disease. In addition, 1 in every 20 Americans o...
Find MoreIn recent years, Probiotics and prebiotics products have gained intense development and attention from the scientific, researchers, and healthcare giants due to their beneficial roles in maintaining human health. Several clinical studies have demonstrated a positive effect of probiotics on gastrointestinal diseases...
Find MoreNovartis Announces the Positive Results of Phase III NATALEE trial Evaluating Kisqali Novartis announced positive topline results from an interim analysis of NATALEE, a Phase III trial evaluating Kisqali® (ribociclib) plus endocrine therapy (ET) in a broad population of patients with hormone receptor-positive/hu...
Find MoreTriglycerides, the energy-providing lipids consumed from fat-containing food, have been known to cause severe health conditions in high levels, including acute pancreatitis. It is also associated with apolipoprotein C-III (APOCIII) and high probability of coronary artery disease (CAD). Triglyceride levels above a c...
Find MoreAbbVie Announces Positive Results of Study Evaluating SKYRIZI in Plaque Psoriasis Patients AbbVie announced new 52-week data from an open-label, a single-arm study demonstrating improved plaque psoriasis signs and symptoms in a difficult-to-treat patient population who received SKYRIZI® (risankizumab), an IL-23 ...
Find MoreObesity is the second most common cause of preventable death, associated with the risk of developing inflammatory components, directly and indirectly, related to cardiovascular disease, diabetes mellitus, respiratory problems, psychological issues, hypertension, obstructive sleep apnea, cancer, and hyperlipidemia. ...
Find MoreOncology has become a growing area of interest for pharmaceutical companies over the years. With a significant increase in R&D and healthcare spending worldwide, companies ranging from large pharmaceutical conglomerates to smaller biotech organizations are frantically attempting to capitalize on lucrative marke...
Find MoreVascular Dementia (VaD) is a common type of Dementia caused by reduced blood flow to the brain. VaD .....
Find MoreAlzheimer's disease is an irreversible, progressive disorder of the brain that progressively destroy.....
Find MoreDevelopmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are cha.....
Find MoreThe medical device industry is experiencing rapid change as innovation is accelerating, new business.....
Find MoreBlastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare form of neoplasm, generally .....
Find MoreAn autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythemat.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.